Experimental drug yields dramatic weight loss
An experimental shot helped participants in a large trial lose far more weight than obesity drugs already on the market, Eli Lilly, the maker, announced Thursday.
Obesity drugs linked to stalling cancer
- How GLP-1s are more than just weight-loss wonders – but not without risk South China Morning Post —
- Weight-loss drugs from Lilly, Novo linked to stalling cancer: report Seeking Alpha —
- Eli Lilly’s next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial The Indian Express —
- New weight-loss drug Retatrutide showing stronger results than current options CBS News —
- Dr. Alok Patel breaks down Ebola concerns and new weight loss drug 📹 ABC News — · 1min